Cell transplant study for moderate Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 70 years old
- You have been diagnosed with Parkinson's disease for at least 5 years
- Your Parkinson's is at a moderate stage, and your symptoms don't improve enough with current medications
- Your body responds well to levodopa (a standard Parkinson's medication), as confirmed by your doctor
- You have no major brain injuries or abnormalities on MRI scans
- Your blood counts, liver, and kidney function are within acceptable ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called NouvNeu001 for people with Parkinson's disease. It aims to see if it's safe, feasible, and effective in improving motor symptoms.
This trial studies whether a special type of stem cell treatment can help people with Parkinson's disease or certain atypical parkinsonism conditions. The treatment involves harvesting your own bone marrow stem cells and optimizing them in the lab before giving them back to you. It aims to see if this can slow down the disease or improve symptoms.
This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.
This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
Hear when a new Parkinson Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.